The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.
about
NMDA receptors in clinical neurology: excitatory times ahead.The endocannabinoid system as a target for the treatment of motor dysfunction.Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models.Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine.
P2860
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.
@ast
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.
@en
type
label
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.
@ast
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.
@en
prefLabel
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.
@ast
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.
@en
P921
P1433
P1476
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease
@en
P2093
Brotchie JM
P304
S105-12; discussion S112-4
P433
P577
2000-04-01T00:00:00Z